23-26 September Glasgow
| 12-PA | A Protocolised Multidisciplinary Workflow for Early Myeloma Directed Therapy in Suspected Light Chain Cast Nephropathy: Outcomes from a Multi-Hospital Network | Xinjie Jonathan Tang | |
| 15-NSP | Impact of premedication de-escalation on the incidence of infusion-related reactions with isatuximab | Tyler Sandahl | |
| 41-PA | Atrial fibrillation in multiple myeloma: High prevalence, incidence and impact on survival. A population-based study on 8 672 patients diagnosed 2008-2021 from the Swedish Myeloma Registry. | Karin Larsson | |
| 52-PA | Biallelic del(1p) and TP53 mutation rates and their overlap with 2+HRCA high-risk in newly diagnosed multiple myeloma: results of an ISO-accredited NHS Genomics Laboratory Hub | Sina Beer | |
| 245-PA | Impact of prior anti-BCMA antibody-drug conjugate exposure and high-risk cytogenetics on outcomes with BCMA bispecifics in relapsed/refractory multiple myeloma: a single centre real-world analysis | Martin Kaiser | |
| 291-PA | Lysosome-mediated selective removal of eccDNA drives proteasome inhibitor resistance of multiple myeloma by ubiquitination and Piezo1-dependent ESCRT | Huihan Wang | |
| 340-PA | POLB 001, an oral p38 MAPK inhibitor for the prevention of cytokine release syndrome | Liam Tremble | |
| 389-PA | Real-World Dexamethasone Dose Intensity Patterns in Induction Therapy for Newly Diagnosed Multiple Myeloma in a Mexican Cohort | Diego Garzón Recalde | |
| 403-PA | Real-World Outcomes of Anti-CD38-Based Quadruplet Induction Regimens in Newly Diagnosed Multiple Myeloma: A Multinational Latin American Experience. | patricio duarte | |
| 466-PA | Survival Outcomes Associated with Daratumumab Use in Multiple Myeloma: A Retrospective Real-World Cohort Analysis | Diego Cruz-Contreras | |
| 508-PA | Trends and Disparities in Infection Associated Mortality Among Older Adults with Multiple Myeloma: A CDC WONDER Analysis from 1999 to 2023 | Ahad Moulvi | |
23-26 September Glasgow

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|